Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Lavor, N. Antonava, E. Nikolenko (Minsk, Belarus). Candidosis due to treatment pulmonary diseases. Eur Respir J 2009; 34: Suppl. 53, 2553

Member's Comments

No comment yet.

Related content which might interest you: Severe pulmonary infections due to biological therapy of rheumatic diseases Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: 782-800 Year: 2007 COPD and other pulmonary diseases Source: Eur Respir Monogr 2015; 67: 161-178 Year: 2015 Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007 Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Updates in pulmonary hypertension and other pulmonary vascular diseases Source: Breathe, 15 (3) 241; 10.1183/20734735.0187-2019 Year: 2019 Early diagnosis of invasive pulmonary aspergillus in patients with chronic obstructive pulmonary diseases: a case control study Source: International Congress 2019 – Airway infection in COPD Year: 2019 Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases. Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 Pulmonary hypertension in interstitial lung diseases Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012 Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Videothoracoscopy in the differential diagnosis disseminated pulmonary diseases Source: International Congress 2016 – Special issues in thoracic surgery Year: 2016 Fungal VAP Source: Eur Respir Mon 2011; 53: 122-137 Year: 2011 Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD) Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005